APO RESEARCH · REPORT
New Medical Materials and Biomaterials
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
Product & engineering
Understand the product.
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
Selected research
Industry Growth & Trends
Global New Medical Materials and Biomaterials Industry Growth and Trends Forecast to 2032
Market perspective
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
According to APO Research, the global New Medical Materials and Biomaterials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global New Medical Materials and Biomaterials market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The New Medical Materials and Biomaterials market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global New Medical Materials and Biomaterials market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to New Medical Materials and Biomaterials.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global New Medical Materials and Biomaterials market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
New Medical Materials and Biomaterials Market by Company
STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies
New Medical Materials and Biomaterials Segment by Type
Medical Polymers
Bioceramics
Medical 3D Printing Materials
Membranes
Surface Modifications
Others
New Medical Materials and Biomaterials Segment by Application
Packaging
Transplant Components
Dental Products
Catheters
Others
New Medical Materials and Biomaterials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of New Medical Materials and Biomaterials companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Polymers
- Bioceramics
- Medical 3D Printing Materials
- Membranes
- Surface Modifications
- Others
Applications
- Packaging
- Transplant Components
- Dental Products
- Catheters
- Others
Companies covered
- STR
- Avitus
- Sagemax
- Stratasys
- Formlab
- NanoH2O (LG)
- Covalent-coating
- Nasseo
- TriboFilm
- ACS material
- Palmaz Scientific
- Invibio
- Secant Medical
- TeraPore Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global New Medical Materials and Biomaterials Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global New Medical Materials and Biomaterials Market Size by Region (2021-2032)
- 1.4.1 Global New Medical Materials and Biomaterials Market Size by Region (2021-2026)
- 1.4.2 Global New Medical Materials and Biomaterials Market Size by Region (2027-2032)
- 1.5 Key Regions New Medical Materials and Biomaterials Market Size (2021-2032)
- 1.5.1 North America New Medical Materials and Biomaterials Market Size Growth Rate (2021-2032)
- 1.5.2 Europe New Medical Materials and Biomaterials Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific New Medical Materials and Biomaterials Market Size Growth Rate (2021-2032)
- 1.5.4 South America New Medical Materials and Biomaterials Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa New Medical Materials and Biomaterials Market Size Growth Rate (2021-2032)
2 New Medical Materials and Biomaterials Market by Type
- 2.1 Type Introduction
- 2.1.1 Medical Polymers
- 2.1.2 Bioceramics
- 2.1.3 Medical 3D Printing Materials
- 2.1.4 Membranes
- 2.1.5 Surface Modifications
- 2.1.6 Others
- 2.2 Global New Medical Materials and Biomaterials Market Size by Type
- 2.2.1 Global New Medical Materials and Biomaterials Market Size Overview by Type (2021-2032)
- 2.2.2 Global New Medical Materials and Biomaterials Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global New Medical Materials and Biomaterials Market Size Forecasted by Type (2027-2032)
- 2.3 Global New Medical Materials and Biomaterials Market Size by Regions
- 2.3.1 North America New Medical Materials and Biomaterials Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe New Medical Materials and Biomaterials Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific New Medical Materials and Biomaterials Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America New Medical Materials and Biomaterials Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa New Medical Materials and Biomaterials Market Size Breakdown by Type (2021-2026)
3 New Medical Materials and Biomaterials Market by Application
- 3.1 Type Introduction
- 3.1.1 Packaging
- 3.1.2 Transplant Components
- 3.1.3 Dental Products
- 3.1.4 Catheters
- 3.1.5 Others
- 3.2 Global New Medical Materials and Biomaterials Market Size by Application
- 3.2.1 Global New Medical Materials and Biomaterials Market Size Overview by Application (2021-2032)
- 3.2.2 Global New Medical Materials and Biomaterials Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global New Medical Materials and Biomaterials Market Size Forecasted by Application (2027-2032)
- 3.3 Global New Medical Materials and Biomaterials Market Size by Regions
- 3.3.1 North America New Medical Materials and Biomaterials Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe New Medical Materials and Biomaterials Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific New Medical Materials and Biomaterials Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America New Medical Materials and Biomaterials Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa New Medical Materials and Biomaterials Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 New Medical Materials and Biomaterials Industry Trends
- 4.2 New Medical Materials and Biomaterials Industry Drivers
- 4.3 New Medical Materials and Biomaterials Industry Opportunities and Challenges
- 4.4 New Medical Materials and Biomaterials Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by New Medical Materials and Biomaterials Revenue (2021-2026)
- 5.2 Global New Medical Materials and Biomaterials Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global New Medical Materials and Biomaterials Key Company Headquarters & Area Served
- 5.4 Global New Medical Materials and Biomaterials Company, Product Type & Application
- 5.5 Global New Medical Materials and Biomaterials Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global New Medical Materials and Biomaterials Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 New Medical Materials and Biomaterials Players Market Share by Revenue in 2025
- 5.6.3 2025 New Medical Materials and Biomaterials Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 STR
- 6.1.1 STR Company Information
- 6.1.2 STR Business Overview
- 6.1.3 STR New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 STR New Medical Materials and Biomaterials Product Portfolio
- 6.1.5 STR Recent Developments
- 6.2 Avitus
- 6.2.1 Avitus Company Information
- 6.2.2 Avitus Business Overview
- 6.2.3 Avitus New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
- 6.2.5 Avitus Recent Developments
- 6.3 Sagemax
- 6.3.1 Sagemax Company Information
- 6.3.2 Sagemax Business Overview
- 6.3.3 Sagemax New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
- 6.3.5 Sagemax Recent Developments
- 6.4 Stratasys
- 6.4.1 Stratasys Company Information
- 6.4.2 Stratasys Business Overview
- 6.4.3 Stratasys New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
- 6.4.5 Stratasys Recent Developments
- 6.5 Formlab
- 6.5.1 Formlab Company Information
- 6.5.2 Formlab Business Overview
- 6.5.3 Formlab New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
- 6.5.5 Formlab Recent Developments
- 6.6 NanoH2O (LG)
- 6.6.1 NanoH2O (LG) Company Information
- 6.6.2 NanoH2O (LG) Business Overview
- 6.6.3 NanoH2O (LG) New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
- 6.6.5 NanoH2O (LG) Recent Developments
- 6.7 Covalent-coating
- 6.7.1 Covalent-coating Company Information
- 6.7.2 Covalent-coating Business Overview
- 6.7.3 Covalent-coating New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
- 6.7.5 Covalent-coating Recent Developments
- 6.8 Nasseo
- 6.8.1 Nasseo Company Information
- 6.8.2 Nasseo Business Overview
- 6.8.3 Nasseo New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
- 6.8.5 Nasseo Recent Developments
- 6.9 TriboFilm
- 6.9.1 TriboFilm Company Information
- 6.9.2 TriboFilm Business Overview
- 6.9.3 TriboFilm New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
- 6.9.5 TriboFilm Recent Developments
- 6.10 ACS material
- 6.10.1 ACS material Company Information
- 6.10.2 ACS material Business Overview
- 6.10.3 ACS material New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
- 6.10.5 ACS material Recent Developments
- 6.11 Palmaz Scientific
- 6.11.1 Palmaz Scientific Company Information
- 6.11.2 Palmaz Scientific Business Overview
- 6.11.3 Palmaz Scientific New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
- 6.11.5 Palmaz Scientific Recent Developments
- 6.12 Invibio
- 6.12.1 Invibio Company Information
- 6.12.2 Invibio Business Overview
- 6.12.3 Invibio New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
- 6.12.5 Invibio Recent Developments
- 6.13 Secant Medical
- 6.13.1 Secant Medical Company Information
- 6.13.2 Secant Medical Business Overview
- 6.13.3 Secant Medical New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
- 6.13.5 Secant Medical Recent Developments
- 6.14 TeraPore Technologies
- 6.14.1 TeraPore Technologies Company Information
- 6.14.2 TeraPore Technologies Business Overview
- 6.14.3 TeraPore Technologies New Medical Materials and Biomaterials Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
- 6.14.5 TeraPore Technologies Recent Developments
7 North America
- 7.1 North America New Medical Materials and Biomaterials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 7.3 North America New Medical Materials and Biomaterials Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe New Medical Materials and Biomaterials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 8.3 Europe New Medical Materials and Biomaterials Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific New Medical Materials and Biomaterials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 9.3 Asia-Pacific New Medical Materials and Biomaterials Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America New Medical Materials and Biomaterials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 10.3 South America New Medical Materials and Biomaterials Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa New Medical Materials and Biomaterials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 11.3 Middle East & Africa New Medical Materials and Biomaterials Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst